Compare AJANTA PHARMA with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA FDC LTD. AJANTA PHARMA/
FDC LTD.
 
P/E (TTM) x 21.6 16.4 131.5% View Chart
P/BV x 3.8 2.2 171.3% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 AJANTA PHARMA   FDC LTD.
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
FDC LTD.
Mar-18
AJANTA PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs1,422319 445.7%   
Low Rs898164 547.3%   
Sales per share (Unadj.) Rs233.561.6 378.8%  
Earnings per share (Unadj.) Rs44.09.9 441.9%  
Cash flow per share (Unadj.) Rs52.212.0 435.9%  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.173.2 348.6%  
Shares outstanding (eoy) m88.02174.40 50.5%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x5.03.9 126.8%   
Avg P/E ratio x26.424.3 108.7%  
P/CF ratio (eoy) x22.220.2 110.2%  
Price / Book Value ratio x4.53.3 137.8%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,08142,118 242.4%   
No. of employees `0006.85.5 122.9%   
Total wages/salary Rs m4,3072,167 198.8%   
Avg. sales/employee Rs Th3,022.61,943.7 155.5%   
Avg. wages/employee Rs Th633.4391.7 161.7%   
Avg. net profit/employee Rs Th569.1313.7 181.4%   
INCOME DATA
Net Sales Rs m20,55410,751 191.2%  
Other income Rs m211510 41.4%   
Total revenues Rs m20,76511,260 184.4%   
Gross profit Rs m5,6642,267 249.9%  
Depreciation Rs m721351 205.1%   
Interest Rs m1214 82.9%   
Profit before tax Rs m5,1432,411 213.3%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273671 189.7%   
Profit after tax Rs m3,8701,735 223.0%  
Gross profit margin %27.621.1 130.7%  
Effective tax rate %24.827.8 88.9%   
Net profit margin %18.816.1 116.7%  
BALANCE SHEET DATA
Current assets Rs m11,8127,213 163.8%   
Current liabilities Rs m3,7762,104 179.5%   
Net working cap to sales %39.147.5 82.3%  
Current ratio x3.13.4 91.2%  
Inventory Days Days7754 142.0%  
Debtors Days Days8228 294.3%  
Net fixed assets Rs m14,3986,865 209.7%   
Share capital Rs m175175 100.1%   
"Free" reserves Rs m22,27712,586 177.0%   
Net worth Rs m22,45212,761 175.9%   
Long term debt Rs m76 110.0%   
Total assets Rs m26,96215,041 179.3%  
Interest coverage x444.3173.2 256.5%   
Debt to equity ratio x00 62.5%  
Sales to assets ratio x0.80.7 106.7%   
Return on assets %14.411.6 123.8%  
Return on equity %17.213.6 126.8%  
Return on capital %23.019.0 121.1%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,6821,889 565.5%   
Fx outflow Rs m2,1020-   
Net fx Rs m8,5801,889 454.2%   
CASH FLOW
From Operations Rs m3,7481,498 250.1%  
From Investments Rs m-2,228201 -1,107.9%  
From Financial Activity Rs m-1,475-1,694 87.0%  
Net Cashflow Rs m4510 438.8%  

Share Holding

Indian Promoters % 73.8 68.9 107.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 4.7 33.0%  
FIIs % 7.6 7.5 101.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 19.0 89.5%  
Shareholders   20,968 23,730 88.4%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES  GLENMARK PHARMA  SHASUN PHARMA  FRESENIUS KABI ONCO.  J.B.CHEMICALS  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

DHFL Saga, Falling Passenger Vehicle Sales, and Top Cues in Focus Today(Pre-Open)

Indian share markets witnessed buying interest on Friday and ended their volatile trading session on a positive note.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Oct 11, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS